Acceder

Publicaciones - Investigación en Pediatría

Cargando...
Miralles-Lopez JC, Cortes Collado JJ, Petryk Petryk Y, Bravo-Gutierrez FJ, Andujar-Espinosa R, Ramirez Hernandez M, Castilla-Martinez M, Diaz-Chantar C, Ibarra-Calabuig I, Valverde-Molina J, Perez-Fernandez V, Group RA. Real-life efficacy of Tezepelumab in patients with failure to other biologic drugs. Eur Ann Allergy Clin Immunol. 2025 Oct 10. doi: 10.23822/EurAnnACI.1764-1489.416. Online ahead of print. No abstract available. PubMed PMID: 41070810.
AÑO: 2025; IF: 2.3
Alvarez-Gutierrez FJ, Casas-Maldonado F, Valverde-Molina J. News From the Severe Asthma Consensus 2025 Review. Arch Bronconeumol. 2025 Nov 14:S0300-2896(25)00409-0. doi: 10.1016/j.arbres.2025.11.003. Online ahead of print. No abstract available. English, Spanish. PubMed PMID: 41314900.
AÑO: 2025; IF: 9.2
Gupta A, de Mir Messa I, Valverde-Molina J, Murray CS, Moral L, Torres Borrego J, Pike K, Diaz-Izquierdo A, Martinez-Canavate A, Nagakumar P, Cook J, Gupta L; CASAM Group. Protocol for an open labelled observational study in children & adolescents with severe asthma with an eosinophilic phenotype treated with mepolizumab (CASAM). PLoS One. 2025 Dec 19;20(12):e0335399. doi: 10.1371/journal.pone.0335399. eCollection 2025. PubMed PMID: 41417800; PubMed Central PMCID: PMC12716689.
AÑO: 2025; IF: 2.6
Almonacid C, Quirce S, Blanco M, Del Cubillo A, Valverde-Molina J, Plaza V. Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management. Arch Bronconeumol. 2025 Dec 2:S0300-2896(25)00418-1. doi: 10.1016/j.arbres.2025.11.011. Online ahead of print. English, Spanish. PubMed PMID: 41421866.
AÑO: 2025; IF: 9.2
Galan Carrillo I, Galbis Martinez L, Martinez V, Roca Merono S, Ramos F, Gonzalez Rodriguez JD, Pinero Fernandez J, Guillen Navarro E. Multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. Nefrologia (Engl Ed). 2024 Jan-Feb;44(1):69-76. doi: 10.1016/j.nefroe.2024.02.002. Epub 2024 Feb 27. PubMed PMID: 38418364.
AÑO: 2024
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII